Thursday, December 29, 2011

BK Medical Receives Coveted Frost & Sullivan Award in Surgical Ultrasound Market

PEABODY, Mass., Dec 29, 2011 (GlobeNewswire via COMTEX) -- BK Medical, part of Analogic's ultrasound group ALOG +1.74% , announced that it has received the 2011 Frost & Sullivan North American Product Differentiation Excellence of the Year Award in the Surgical Ultrasound Market. BK Medical recently highlighted this prominent award at the Radiological Society of North America (RSNA) 97th Scientific Assembly and Annual Meeting.

"Our noteworthy accomplishments in ultrasound reflect innovation and excellence in product engineering and design, which is evidenced by our comprehensive range of ultrasound systems, including Advanced Robotics Ultrasound Technology(TM) (ART(TM)), the industry's first complete imaging solution for robotic-assisted surgery that includes the Flex Focus(TM) 700 Ultrasound System," said Lars Shaw, Analogic's vice president of global marketing. "We are committed to providing our customers with the most advanced ultrasound imaging modalities, and we are truly honored to be recognized by Frost & Sullivan in the Product Differentiation Excellence category.

source: MarketWatch

Sunday, December 25, 2011

SonoSite Begins International Shipments of New EDGE Ultrasound System

BOTHELL, Wash., Dec 21, 2011 (BUSINESS WIRE) -- SonoSite, Inc. SONO -0.15% , the world leader and specialist in hand-carried ultrasound for the point-of-care, announced it has received CE Marking (Conformite Europeenne) in the European Union to market its next generation point-of-care product: EDGE(TM) ultrasound system. The EDGE system is currently available for sale in the U.S., following receipt of FDA Premarket Notification 510(k) clearance in November. SonoSite is now commencing international customer deliveries.

Engineered with new state-of-the-art technology, the EDGE ultrasound system takes point-of- care ultrasound to a whole new level of clinical performance and enables physicians to deliver the highest standard of patient care by driving greater efficiencies and the potential for improved outcomes in the hospital and office.

The EDGE ultrasound was formally introduced this fall at medical meetings and congresses in Europe and Australia. Physicians positively responded to the system:

"As a faithful SonoSite user, I want the company's products to remain true to its core elements, namely user friendliness, simplicity of use and rapid acquisition of a great image," said Amit Pawa, MD, Anesthesiologist Consultant, Guy's and St. Thomas' NHS Foundation Trust, London, UK. "The EDGE system clearly accomplishes this while looking futuristic, sleek and sophisticated. Physicians will also benefit from the back-lit screen and wipe-able keypad. Overall, the image quality is superior and I can't wait to use it in clinical practice."

source: SonoSite

Friday, December 16, 2011

Fujifilm Holdings Announces Agreement to Acquire SonoSite, Inc.

TOKYO & BOTHELL, Wash., Dec 15, 2011 (BUSINESS WIRE) -- FUJIFILM Holdings Corporation (hereinafter:Fujifilm), a diversified technology company that operates in healthcare, highly functional materials, and document solutions, announced today that it has entered into a definitive agreement with SonoSite, Inc. SONO +0.00% (hereinafter:SonoSite), a pioneer and leader in bedside and point-of-care ultrasound technology, pursuant to which Fujifilm will acquire SonoSite for approximately $995 million (which includes amounts payable in connection with its convertible debt). The transaction was unanimously approved by the Boards of Directors of both companies.

Fujifilm, through a U.S. subsidiary, will make an all-cash tender offer to purchase all outstanding shares of SonoSite common stock for $54 per share in cash. The purchase price represents a premium of 50.0% over SonoSite's average closing stock price over the three months ended December 14, 2011, and a 75.4% premium over the closing price on November 2, 2011, the last trading day before news reports relating to a possible sale transaction were first published. The tender offer is scheduled to commence within 20 business days and will remain open for 21 U.S. business days.

source: MarketWatch

Tuesday, November 29, 2011

Zonaire Medical Systems to Showcase Ultrasound Platform at RSNA

CHICAGO, November 28, 2011 - ZONARE Medical Systems, Inc., a developer of premium ultrasound solutions, will showcase the system focused on abdominal ultrasound imaging solutions for diverse patient populations here shown at the 97th Annual Meeting of the Radiology Society of North America, November 27 – December 2.

ZONARE’s ultrasound system delivers high-end image quality powered by its proprietary Zone Sonography™ Technology (ZSTTM) which compensates for speed of sound variations across patients enabling optimum image quality among a diverse patient population. The system delivers stellar performance and provides mobility and workflow advantages across a wide variety of radiology applications, ranging from neonatal to bariatric patients.

"In my experience, the highly mobile ZONARE system delivers premium pediatric imaging performance in practical applications. Using the C10-3, C9-3 and C6-2 transducers provides consistently uniform imaging at depth on neonates to teenagers with color Doppler performance comparable to our other premium systems," said Dr. Brian Coley, radiologist-in-chief at Cincinnati Children’s Hospital Medical Center.

source: Zonaire

Monday, November 28, 2011

Toshiba Launches Aplio 500 Ultrasound with Advanced Fly Thru and Smart Fusion Features

CHICAGO, Nov 27, 2011 (BUSINESS WIRE) -- Toshiba America Medical Systems, Inc., launched the Aplio(TM) 500 ultrasound system, enabling clinicians to diagnose like never before, using the most advanced visualization tools in the industry. The Aplio 500 ultrasound is 510(k) cleared and displayed at the Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 27 -- Dec. 2, 2011 (Booth #5634, South Hall).

Aplio 500 combines advanced visualization capabilities, workflow automation tools and superior ergonomics for more accurate diagnoses and improved departmental efficiency. The system is backed by Toshiba's Reliance Program, the industry's best warranty/technology protection program.

Toshiba's Aplio 500 comes optional with Fly Thru and Smart Fusion, two advanced features unmatched in the industry:

-- Fly Thru: This industry-first technology revolutionizes ultrasound diagnosis using 3D volume rendering to "fly through" interiors of ducts and vessels for better exploration of lesions and masses, and to assist in planning interventional procedures. Fly Thru gives clinicians an entirely new perspective of 3D imaging.

-- Smart Fusion: Shows both CT and ultrasound images side-by-side on a single screen. Smart Fusion syncs the two images, helping to locate hard-to-find lesions and aiding in ultrasound-guided biopsy without additional CT scans. Toshiba's Smart Fusion is easy to use, with the most intuitive user set-up available.

source: Market Watch

Monday, October 31, 2011

ICUS Applauds FDA Modification of Boxed Warnings on Certain Ultrasound Contrast Agents; Cite Patient Benefit

WASHINGTON--(EON: Enhanced Online News)--International Contrast Ultrasound Society (ICUS) today applauded the FDA’s decision to modify the U.S. product label for DEFINITY® Injectable Suspension, an ultrasound contrast agent. Ultrasound contrast agents are approved in the U.S. for cardiac imaging and do not expose patients to ionizing radiation.

ICUS, a cross-specialty society of international medical experts, filed a Citizen Petition with the FDA in September asking the agency to remove boxed warnings from ultrasound contrast agents, stating that the warnings deter use of a safe, inexpensive and radiation-free diagnostic imaging tool with potential life-saving benefits for patients.

“The FDA decision should lead to increased use of contrast, better imaging studies, better diagnosis for patients, and saved lives,” according to Dr. Michael Main, an expert in contrast ultrasound safety and Treasurer of ICUS. Main is a cardiologist and director of the echocardiography laboratory at Saint Luke’s Mid-America Heart Institute in Kansas City.

Main said that although the FDA’s current boxed warnings for ultrasound contrast agents are not warranted by safety data, the label modification for DEFINITY® “makes important incremental progress based on sound science that now more accurately reflects the risk benefit profile.”

source: Business Wire

Monday, October 24, 2011

New Vascular Ultrasound Tables from Biodex

Biodex Medical Systems, Inc., Shirley, N.Y., will introduce two new vascular imaging tables at the Radiological Society of North America (RSNA) meeting in Chicago, November 27 to December 2, 2011. Excitement is building at the anticipation of new advancements in medical imaging; Biodex is thrilled to be part of the driving force for bringing new products to this field.

After an extensive research and development phase, the new Vascular Ultrasound Tables are ready to meet the demands of medical imaging. “We have been working hard to broaden our product line for our customers while also being on the forefront of the latest technologies for this industry with two new tables to choose from,” explained Rich Schubert, Radiology Sales for Biodex Medical Systems, Inc.

The Vasc Pro Vascular Ultrasound Table can be described as the best solution for any type of long leg vascular procedure including Venous mapping, DVT, Venous ablation, PAD and many more procedures. The Vasc Pro is also an economical choice when performing vascular scanning. The table design will also help improve images by providing a 30-degree reverse Trendelenburg position. The table is considered so accommodating that it reduces the total amount of time required to achieve image quality. The 30-degree position expands lower extremity veins for maximum vessel dilation as well as faster and easier recognition of structures.

The new Echo/Vasc Pro Vascular Ultrasound Table is the logical choice when performing vascular scanning and echocardiography, to view arteries, veins and heart chambers. The Echo/Vasc Pro provides the same convenient solutions to these procedures as the Vasc/Pro while also providing the same ergonomic benefit as our popular Echo Pro table. As always, ergonomics is the key ingredient in all Biodex Ultrasound tables. Sonographer safety and optimal imaging potential makes Biodex tables the first choice of most facilities.

source: PR Web

Monday, July 18, 2011

Abnormal Brain Ultrasounds in Premature Infants Indicate Future Risk of Psychiatric Disorders

Infants born prematurely are at risk for injuries to the white and gray matter of the brain that affect cortical development and neural connectivity. Certain forms of these injuries can be detected in the neonatal period using ultrasound, according to Columbia University Medical Center researchers.

Researchers who followed a group of premature infants until age 16 found that those with neonatal ultrasound abnormalities were at increased risk for specific psychiatric disorders, namely, attention deficit hyperactivity, tic disorders, obsessive compulsive disorder, and major depression―all of which are thought to arise from dysfunctions of the subcortical-cortical circuits. The findings were published in the July 2011 issue of the Archives of General Psychiatry.

Premature birth is a growing problem in the United States, adding to the significance of the findings. An increased appreciation of the relation between perinatal brain injuries and later psychiatric disorders could lead to earlier diagnosis and intervention by the pediatricians, psychiatrists, and neurologists who care for these children and adolescents. Future research may also explore the relation of perinatal brain injury to psychiatric disorders, such as schizophrenia, that more commonly come to clinical attention in adulthood.

A research group at Columbia University Medical Center/New York State Psychiatric Institute led by Dr. Agnes Whitaker, MD, evaluated more than 400 nondisabled adolescents who had been born prematurely and had had abnormal brain ultrasounds taken at birth. When the researchers administered questionnaires and cognitive tests to the subjects and interviewed their parents, they found a relation between perinatal brain injuries and certain psychiatric disorders at adolescence that could not be explained by other medical or social factors.

source: Columbia University Medical Center

Saturday, May 7, 2011

Volcano Corporation to Supply Intravascular Ultrasound Technology to Covidien

Volcano Corporation (NASDAQ: VOLC), the leading developer and manufacturer of precision guided therapy tools designed to enhance the treatment of coronary and peripheral vascular disease, today announced the signing of a supply agreement with ev3, a Covidien company, under which Volcano will supply its proprietary Intravascular Ultrasound (IVUS) technology for use in ev3's Plaque Excision Systems. Utilizing the digital IVUS transducer incorporated in Volcano's market leading EagleEye® catheter product line, this new product will be capable of running on Volcano's global installed base of 5,000 systems.

"At Volcano, our imaging and physiology tools provide a level of precision that angiography alone simply cannot match," commented Scott Huennekens, President and CEO of Volcano. "In addition to our internally developed image guided therapy products, such as the VIBE® RX Imaging Balloon (commercially available in the EU only), we have looked to other medical device industry leaders to join us in differentiating therapeutic devices by adding integrated imaging capabilities. Covidien is an innovative company that recognizes the value of onboard visualization and is committed to bringing these new, more precise therapies to market to help improve patient outcomes. This agreement also exemplifies the value of our one system, many solutions strategy facilitated by our multi-modality platform."

source: Volcano

Monday, May 2, 2011

Surgeons Get FIT for Breast Health with Terason Ultrasound

BURLINGTON, Mass.--(BUSINESS WIRE)--Terason, the innovator and leader in laptop ultrasound technology today announced the release of the Terason t3200™ Ultrasound System – Breast Series. This fully-functional, portable ultrasound system is the first of its kind designed specifically for the Breast Surgeon.

David Kaufman, Chief of Breast Surgery at St. Joseph’s Hospital in Bethpage, NY stated, "The Terason t3200 is a dedicated Breast Ultrasound system that is truly in a class by itself, with state-of-the-art digital quality imaging in a portable laptop format that is fully integrated into an Apple MacBook Pro. Simply stated, the Terason t3200 is a unique system that not only is a fully functional laptop PC, but is a fully equipped ultrasound system as well. This unique feature, seen only in this Terason unit, will allow any physician to streamline their workflow, allowing more time to provide diagnostic and interventional ultrasound to their patients. One can scan and store images and reports directly on the laptop, plus they can be e-mailed directly to referring physicians. The image quality is outstanding and far superior compared to other laptop-style ultrasound units. In short, the Terason t3200 is easy to use and inexpensive to purchase. This system stands alone as best in category.”

The t3200 Breast Series is the second release in a family of Terason systems with a new wave of advancements in ground-breaking technology. FIT, exclusively from Terason, provides Flexible Imaging Technology using innovative new features to produce high quality images and simplify the ultrasound exam. All new X-Site™ Transducers and DDR™ provide top-notch image quality in both superficial and deeper targets to further enhance clinical confidence. A re-designed intuitive interface, with simplified measurements and annotations, will increase productivity and patient throughput.

source: Business Wire

Monday, April 18, 2011

ContextVision Unveils New Cutting Edge Ultrasound Image Enhancement Product Family

BOSTON, Mass. and STOCKHOLM, Sweden – April 11, 2011 – At the American Institute of Ultrasound in Medicine (AIUM) Annual Convention this week, ContextVision, the software imaging partner for the most recognized medical imaging manufacturers worldwide, will unveil its cutting-edge ultrasound image enhancement family, US PLUSView™. This modular family enables equipment manufacturers to deliver a full range of ultrasound image enhancement capabilities to their customers, including deeper penetration and improved speckle reduction features for the obese and other technically difficult patients.

Following the global obesity epidemic, an increasing portion of all abdominal scans is considered technically difficult since obesity impacts the clinicians´ ability to interpret ultrasound images. ContextVision has designed the US PLUSView product family to extend ultrasound imaging capabilities for these patients. The US PLUSView family includes a modular series of products that offer leading-edge diagnostic capabilities for the clinicians. The unique US PLUSView product family sets new standards as it enables directed, focused image enhancement (DFE) of selected areas, depths and intensities without sacrificing overall image quality.

source: Cision Wire

Monday, April 11, 2011

TechniScan's Breast Imaging Science Featured at National Ultrasound Conference

SALT LAKE CITY, April 11, 2011 /PRNewswire/ -- TechniScan's (OTC BB: TSNI) novel breast ultrasound technology and clinical results will be featured at the American Institute of Ultrasound Medicine's annual conference in New York this week.

As part of an educational session on advanced breast ultrasound imaging, Michael Andre, Ph.D., director of an ongoing clinical study at the University of California, San Diego Moores Cancer Center that enlists TechniScan's automated Warm Bath Ultrasound (WBU) technology, will be leading the discussion and explaining the latest results of the WBU ultrasound system.

TechniScan's WBU system not only employs the well-known properties of reflection ultrasound but also maps the breast by sending transmission ultrasound waves through it, which significantly improves the clinical information and may allow a radiologist to determine whether a breast lesion is a cyst, a benign fibroademona or a malignancy – without a biopsy.

Two of the world's leading experts on transmission ultrasound and the mathematics of inverse scattering, James Wiskin, Ph.D., a TechniScan founder and adjunct professor at the University of Utah Department of Bioengineering, along with his colleague David Borup, Ph.D., are co-authors on the study. Wiskin will also be participating in the New York session.

"This conference is a great opportunity for other physicians and scientists to learn of the scientific and medical advances the TechniScan system demonstrates," said Andre.

source: PR Newswire

Wednesday, April 6, 2011

Toshiba Introduces Enhancements On Its Ultrasound Product Line To Improve Cardiac Diagnostic Capabilities

Ultrasound is often used as a first-line diagnostic exam to quickly and safely diagnose a range of patient conditions. At this year's American College of Cardiology (ACC) annual meeting in New Orleans, April 2 - 5, 2011 (Booth # 2847), Toshiba America Medical Systems, Inc., will highlight new enhancements to its cardiac and shared service ultrasound systems that are designed to enhance cardiac ultrasound imaging.

"Toshiba is dedicated to continuously improving its imaging systems to meet the changing needs of healthcare providers," said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. "These enhancements to the ultrasound product line build upon Toshiba's advanced technology to allow quicker, safer and more effective diagnosis, particularly for cardiac exams."

New enhancements include:

- 3D Wall Motion Tracking and Tissue Enhancement for the Aplio Artida
- Auto IMT on Toshiba's Shared Service Ultrasound Systems
- New TEE Probe

source: Toshiba Medical

Thursday, March 24, 2011

BK Medical Introduces Revolutionary Advanced Robotic Ultrasound Technology (ART) for Prostate Imaging at European Association of Urology Congress

PEABODY, Mass., March 24, 2011 (GLOBE NEWSWIRE) -- BK Medical, a wholly owned subsidiary of Analogic Corporation (Nasdaq:ALOG), introduced Advanced Robotic Ultrasound Technology™ (ART™), the industry's first complete ultrasound imaging solution for robotic surgery. This revolutionary technology, which includes the Flex Focus™ 700 Ultrasound System, specialized transducers, and tools designed specifically for robotic-assisted surgery, was introduced at the 20th Annual European Association of Urology (EAU) Congress in Vienna, March 18-22. ART is a premium performance ultrasound solution that may benefit surgeons performing robotic-assisted radical prostatectomy (RARP) procedures, and robotic-assisted partial nephrectomy (RAPN) procedures.

"BK Medical has been working closely with a leading robotic-assisted surgery company, along with surgeons, to develop the ART ultrasound solution to address robotic-assisted surgery needs of today and tomorrow," said Michael Brock, president of BK Medical. "ART technology, the result of this successful collaboration, provides clinicians with a valuable tool to assess and monitor robotic-assisted surgery procedures in real time."

BK Medical

Saturday, February 26, 2011

Bedside Ultrasound Becomes a Reality

(NewDesignWorld Press Center) - Clinicians have often referred to ultrasound technology as the "stethoscope of the future," predicting that as the equipment shrinks in size, it will one day be as common at the bedside as that trusty tool around every physician's neck. According to a new report in The New England Journal of Medicine, that day has arrived.

The "Current Concepts" article by Yale School of Medicine clinicians Christopher L. Moore, M.D., and Joshua A. Copel, M.D., outlines how ultrasound use has moved beyond traditional specialties like radiology and is now being routinely employed by clinicians across myriad medical specialties and practice areas. From anesthesia to vascular surgery, Moore and Copel say, the use of ultrasonography has increased across the board, with the biggest growth seen among non-radiologists.Over the past two decades, the equipment used in ultrasonography-a safe, effective and non-invasive form of imaging that aids in diagnosis and guides procedures-has become more compact, higher quality and less expensive, leading to the growth of point-of-care ultrasonography, which is performed and interpreted by the clinician at the bedside.

"Ideally, point-of-care ultrasonography can decrease medical errors, provide more real-time diagnosis, and supplement or replace more advanced imaging in appropriate situations," said Moore, assistant professor in the Department of Emergency Medicine at Yale School of Medicine. "Point-of-care ultrasonography may also allow more widespread, less expensive screening for certain illnesses."

source: NewDesignWorld

Thursday, February 24, 2011

Conceptus(R) Receives CE Mark for Transvaginal Ultrasound Confirmation for Essure(R) Procedure

MOUNTAIN VIEW, Calif., Feb. 24, 2011 (GLOBE NEWSWIRE) -- Conceptus Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method available, today announced receipt of the CE mark for use of Transvaginal Ultrasound ("TVU") to confirm proper placement of Essure micro-inserts three months following the Essure procedure. TVU is an alternative to the standard flat plate pelvic X-ray, and both will be included in the European Physicians' Instruction for Use. TVU takes place in the physician's clinic, while X-rays typically are taken at a radiology facility.

Essure micro-inserts are radiopaque, which enables physicians to visualize the location of the micro-inserts using either TVU or the standard flat plate pelvic X-ray. TVU is a non-invasive technique that uses sound waves sent out by an ultrasound probe to create a live picture (a sonogram) showing the reproductive organs. TVU advantages for patients include the ability to return to the familiar setting of the physician's clinic and avoid ionizing radiation associated with X-rays. TVU advantages for physicians include more control over the entire Essure procedure and improved patient compliance with the confirmation process.

source: Conceptus

Sunday, February 20, 2011

Toshiba Announces FDA Clearance of Auto-IMT Ultrasound Software

TUSTIN, Calif.--(BUSINESS WIRE)--For physicians, the ability to streamline exams for determining a patient’s risk for cardiovascular disease is important in determining the patient’s clinical pathway. To enhance diagnostic efficiency, Toshiba America Medical Systems, Inc. has introduced Auto-IMT™, an ultrasound software tool that can measure the thickness of the intima-media layers of the carotid artery, for evaluating an asymptomatic patient’s risk of developing cardiovascular disease. Toshiba has recently received FDA clearance for Auto-IMT, and it is now available on the AplioTM XG, Aplio MX and XarioTM XG ultrasound systems.

“Toshiba is committed to improving patient care and providing ways to streamline processes so patients receive the highest quality care more efficiently.”

Toshiba’s Auto-IMT can determine the thickness of the near and far arterial walls from three segments of the carotid artery: at an optimal angle of incidence and two complementary planes. Auto-IMT traces the two complementary planes automatically and calculates the distance between them. The Auto-IMT uses the collected images following the American Society of Echocardiography’s (ASE) consensus statement for the diagnosis.

Toshiba worked with Midwest Ultrasound, a division of The Christ Hospital in Cincinnati, Ohio, to develop the software tool. Midwest Ultrasound is a nationally recognized leader in providing quality cardiac and vascular ultrasound services, and maintains a diverse client mix, from small rural and community hospitals to major urban academic centers and large physician practices in southwest Ohio.

source: Business Wire

Saturday, February 19, 2011

Toshiba Receives FDA Clearance for Viamo Ultrasound System

TUSTIN, Calif., Feb. 4, 2010 – Designed to meet the needs of today’s hospitals by combining portability with high-end radiology features, Toshiba America Medical Systems, Inc.’s new ViamoTM laptop ultrasound system has received FDA clearance. The Viamo is the industry’s no-compromise ultrasound system with advanced radiology capabilities, previously unavailable on hand-carried systems. Toshiba’s Viamo provides the best value in the hand carried class by offering the same premier image quality as larger, more expensive ultrasound systems, but at a lower price point for hospitals. The Viamo was introduced at the 2009 Radiological Society of North America (RSNA) annual meeting.

The Viamo combines the portability of a laptop system with advanced radiology features to deliver outstanding image quality, enhance diagnostic confidence and improve ease of use. Developed from a radiology foundation, Toshiba’s Viamo provides the confidence to image patients at bedside, which generally requires larger, more expensive cart-based systems. When an immobile patient needs a high-end ultrasound exam, the portable Viamo ultrasound is brought to the patient to improve the patient’s comfort without compromising exam quality. It is also ideal for a variety of patient exams, including general radiology, pediatric, emergency, OB/GYN and vascular.

source: Toshiba Medical Systems

Thursday, February 17, 2011

Ultrasound fusion imaging provides comparable accuracy for bone, soft tissue tumors

DETROIT – Biopsies using ultrasound fusion imaging for detecting bone and soft tissue cancers are safe, effective and just as accurate as conventional biopsy methods, according to a Henry Ford Hospital study.

Researchers found that the ultrasound fusion imaging technique guides a needle biopsy with precise accuracy and ease, while making the biopsy experience more convenient for patients.

Ultrasound fusion merges real-time ultrasound images with previously acquired computed tomography or magnetic resonance imaging scans, providing physicians with high resolution, life-like imaging to identify the area for biopsy.

This is the first time researchers compared the safety and efficacy of ultrasound fusion against conventional biopsy imaging tools like CT or MRI.

The study's findings will be presented at the annual meeting of the American Academy of Orthopaedic Surgeons Feb. 15-18 in San Diego.

"Ultrasound fusion is a viable option to consider for patients," says Michael Mott, M.D., an orthopaedic oncologist at Henry Ford and principal investigator for the study. "With imaging precision being equal, patients liked the ultrasound fusion because scheduling a biopsy was found to be more flexible for ultrasound suites than CT suites."

source: EurekAlert

Friday, February 11, 2011

Terason Makes it Easy for MSK Ultrasound to get FIT

BURLINGTON, Mass.--(BUSINESS WIRE)--Terason is transforming the way Musculoskeletal Ultrasound is performed with the new Terason t3200™ Ultrasound System – the first fully-functional, portable ultrasound system designed specifically for the MSK professional.

The t3200 MSK Series is the first in a family of Terason systems with a new wave of advancements in ground-breaking technology. FIT, exclusively from Terason, provides Flexible Imaging Technology using innovative new features to produce high quality images and simplify the ultrasound exam. All new X-Site™ Probes and DDR™ provide top-notch image quality in both superficial and deeper targets to further enhance clinical confidence. A re-designed intuitive interface, with simplified anatomy-specific exam measurements and annotations, will increase productivity and patient throughput.

Terason is proud to ship the first t3200 MSK Ultrasound System to Andrews Institute in Gulf Breeze, FL, a world-class institute for Orthopaedics and Sports Medicine.

source: Business Wire

Wednesday, February 9, 2011

Worlds First Smartphone Based Ultrasound Imaging System Cleared by the FDA

Mobisante, Inc., a privately held medical device company located in Redmond, WA, announced today that it has received 510(k) clearance from the FDA for its smartphone based ultrasound imaging system, MobiUS.

MobiUS is an innovative mobile, affordable, and accessible ultrasound imaging system that uses a smart-phone and Internet cloud services based commercial ultrasound system.

The MobiUS system is indicated for ultrasound imaging, measurement and analysis of the human body for the following clinical applications: fetal/OB, abdominal, cardiac, pelvic, pediatric, musculoskeletal, and peripheral vessel imaging. Its compact size, portability and user interface enable it for use in primary and specialty care. Since MobiUS is based on smartphones it can leverage cellular networks or Wi‐Fi to send images to a remote expert for diagnosis or second opinion, or to a Picture Archiving and Communication System (PACS) for storage.

“Meeting the FDA’s of review is a critical milestone for Mobisante. We will now focus on launching MobiUS in selected markets and pursuing the CE mark in Europe”, said Dr. Salesh Chutan, CEO and co-founder of Mobisante.

MobiUS puts ultrasound capabilities into the hands of healthcare providers everywhere. This immediate access is especially important in rural communities in the U.S.A. and abroad that have limited resources, low population density, or are located far from the urban centers.

Wednesday, February 2, 2011

Microbubble ultrasound and breast biopsies

Using "microbubbles" and ultrasound can mean more targeted breast biopsies for patients with early breast cancer, helping to determine treatment and possibly saving those patients from undergoing a second breast cancer surgery, a new study in shows.

Patients with early breast cancer undergo a sentinel lymph node biopsy to determine if their cancer has spread, said Dr. Ali Sever, lead author of the study. Ultrasound, on its own, can't distinguish the sentinel lymph node from other lymph nodes, Dr. Sever said. However, "our study found that microbubble contrast- enhanced ultrasound accurately identified the sentinel lymph node in 89% of the 80 patients in our study."

As many as 35% of patients who undergo sentinel lymph node excision biopsy will require additional surgery because cancer has spread," Dr. Sever said. Using microbubble contrast-enhanced ultrasound preoperatively means that the cancer and cancer spread can be removed during one operation.

Currently blue dye and radioisotopes are used to identify sentinel lymph nodes at the time of surgical excision. While this technique is accurate, there are side effects for some patients, including an allergic reaction. In addition, the disposal of the radioisotopes (radioactive waste) poses an issue.

source: EurekAlert

Friday, January 28, 2011

Contrast-Enhanced Ultrasound Improves Diagnosis of Medical Conditions in Children

ROTTERDAM, Netherlands--(BUSINESS WIRE)--New research released here Thursday shows that “contrast-enhanced ultrasound” (CEUS) can safely improve the diagnosis of a variety of medical conditions in children – without exposing them to ionizing radiation.

Dr. Martin Stenzel, a pediatric radiologist at the University Hospital in Jena, Germany, reported that no adverse safety event was found when CEUS was used to image some 50 pediatric patients at his hospital.

Stenzel presented his findings at the 16th European Symposium on Ultrasound Contrast Imaging in Rotterdam. The conference, which was co-sponsored by the International Contrast Ultrasound Society (ICUS), featured the latest clinical and research developments in the CEUS field.

“Our experience shows that this technology works in children as well as adults,” Stenzel said.

The youngest patient Stenzel and his colleagues examined with CEUS, was two years old, he said.

Unlike CT and nuclear imaging, ultrasound scans do not expose patients to ionizing radiation – which is associated with an increased lifetime risk of cancer, according to Stenzel.

“It is especially important to avoid subjecting children to diagnostic tests that use ionizing radiation because children have many years to live and the risk of cancer is cumulative,” Stenzel said. “In addition, we do not know how ionizing radiation may affect future reproductive capacity or the impact it may have on their unborn children.”

Stenzel said that since CEUS images are not jeopardized by patient movement, the technique is particularly suitable for imaging young patients who will not lay still. “This avoids the need for sedating children prior to imaging,” he said.

source: Business Wire

Thursday, January 13, 2011

St. Jude Medical Announces Launch of the ViewMate Z Intracardiac Ultrasound System and ViewFlex Plus ICE Catheter

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of its ViewMate(TM) Z Intracardiac Ultrasound System and ViewFlex(TM) Plus Intracardiac Echocardiography (ICE) Catheter.

The ViewMate Z System is designed for real-time image guidance and visualization of the cardiac anatomy. The system is able to deliver fast, high-fidelity images that help direct diagnosis or therapy during complex electrophysiology procedures. The system is compatible with the new ViewFlex(TM) Plus ICE Catheter, which offers improved one-handed control, steering angles up to 120° and enhanced tip stability. The ViewMate Z System is designed to allow clinicians to better visualize a patient's cardiac anatomy and the effects of treatment in real-time.

One of the industry's smallest cart-based systems, the ViewMate Z System offers greater portability and optimizes vital lab space while reducing obstructions in a clinician's workflow. The system was designed, developed and provided through St. Jude Medical's development and distribution agreement with ZONARE Medical Systems, a leading provider of high-end ultrasound systems.

source: St. Jude Medical

Tuesday, January 4, 2011

New Ultrasound Technique Helps Identify Patients Who Need Breast Biopsies

A new ultrasound technique is proving valuable in distinguishing malignant from benign breast lesions in some patients – results that could mean fewer unnecessary breast biopsies, a new study shows.

The study found that ultrasound elastography, which indicates tissue softness, can help predict cancer in patients with BI-RADS category 4 masses. “Because malignant tumors predominantly are harder than benign tissues, this technique significantly improves the differentiation between benign and malignant tissue” said Hiroko Satake, MD, lead author of the study. Dr. Satake is from Nagoya University School of Medicine in Japan.

“In an analysis of 115 breast masses that were recommended for biopsy (they were categorized as either BI-RADS 4 or BI-RADS 5), ultrasound elastography was 79% accurate in identifying cancer,” Dr. Satake said.

“By accurately identifying benign tumors with imaging, we may be able to avoid sending patients for unnecessary biopsies,” Dr. Satake said. Ultrasound elastography provides radiologists with elasticity scores, with lower scores meaning that the mass contains softer tissue. “Based on the results of our study, we recommend that patients with BI-RADS 4 masses should undergo biopsy if their ultrasound elasticity score is 4 or 5,” Dr. Satake said.

source: ARRS